Next Generation Medicines: From Bench to Bed side
Society must be aware about rational and ethical practice of prescribing medicines by the health care professional to the patients, said Dr. Subhash Verma, Director PGIMR Chandigarh. Dr. Verma as a Chief Guest of the event revealed the history and development of Pharmacy in India in the International Conference on the theme Next Generation Medicines from Bench to Bed Side conducted by Chandigarh College of Pharmacy, CGC, Landran sponsored by Society of Pharmaceutical Education and Research (SPER). The objective of the conference was to spread awareness among students and faculty members about how to convert their research into socially and commercially useful product through mass production i.e from Bench (laboratory) to Bed side (useable product). There were 450 participants from various Universities and the international speakers from Canada and Thailand. Dr. Pornsak, Slipakorn University, Bangkok Thailand presented his paper on “Smart Nanogels for Cancer” and Dr. Sukhwinder Bhullar from Victoria University Canada presented her research on “Smart stents and Micro fibrous structures in Bio-medical applications”. Mr. R. K. Singla, Drug controller, Govt. Of Haryana informed the hall regarding the steps being taken by the Govt. to ensure the availability of only rational drug combinations in the market. Dr. Upendra Nagaich, Secretary, SPER society read the achievements of the society since its inception. Dr. Bikash Medhi, Coordinator PGIMER, Chandigarh, Dr. Ashish Ganguly, Principal Scientist, CSIR- Institute of Microbial Technology, Chandigarh, Dr. Kanwaljit Chopra, Professor Panjab University and Dr. Rajwinder Kaur were other key note speakers in the conference. The Students of Pharmacy from various colleges also presented their papr and poster on the above theme. Pankaj Bhatia of PU, Pallavi Bragta of CGC Landran and Anju of Amity University secured first, second and third prize in poster presentation. The conference concluded with the discussion that the major problems faced in commercial production of medicines are unavailability on resources viz. Machines, manpower and technology. Secondly an ongoing research is required to cut down the cost of production without compromising on quality which is a critical issue.